156 related articles for article (PubMed ID: 18557144)
21. Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy.
Intra M; Trifirò G; Viale G; Rotmensz N; Gentilini OD; Soteldo J; Galimberti V; Veronesi P; Luini A; Paganelli G; Veronesi U
Ann Surg Oncol; 2005 Nov; 12(11):895-9. PubMed ID: 16195833
[TBL] [Abstract][Full Text] [Related]
22. Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytologically proven node-positive breast cancer at diagnosis.
Park S; Park JM; Cho JH; Park HS; Kim SI; Park BW
Ann Surg Oncol; 2013 Sep; 20(9):2858-65. PubMed ID: 23645483
[TBL] [Abstract][Full Text] [Related]
23. "Axillary recurrences after sentinel lymph node biopsy: a multicentre analysis and follow-up of sentinel lymph node negative breast cancer patients".
van Wely BJ; van den Wildenberg FJ; Gobardhan P; van Dalen T; Borel Rinkes IH; Theunissen EB; Wijsman JH; Ernst M; van der Pol CC; Madsen EV; Vles WJ; Wauters CA; de Wilt JH; Strobbe LJ
Eur J Surg Oncol; 2012 Oct; 38(10):925-31. PubMed ID: 22633152
[TBL] [Abstract][Full Text] [Related]
24. Successful Completion of the Pilot Phase of a Randomized Controlled Trial Comparing Sentinel Lymph Node Biopsy to No Further Axillary Staging in Patients with Clinical T1-T2 N0 Breast Cancer and Normal Axillary Ultrasound.
Cyr AE; Tucker N; Ademuyiwa F; Margenthaler JA; Aft RL; Eberlein TJ; Appleton CM; Zoberi I; Thomas MA; Gao F; Gillanders WE
J Am Coll Surg; 2016 Aug; 223(2):399-407. PubMed ID: 27212005
[TBL] [Abstract][Full Text] [Related]
25. Positive versus negative sentinel nodes in early breast cancer patients: axillary or loco-regional relapse and survival. A study spanning 2000-2012.
García Fernández A; Chabrera C; García Font M; Fraile M; Lain JM; Barco I; González C; Gónzalez S; Reñe A; Veloso E; Cassadó J; Pessarrodona A; Giménez N
Breast; 2013 Oct; 22(5):902-7. PubMed ID: 23684000
[TBL] [Abstract][Full Text] [Related]
26. Long-term follow-up of 5262 breast cancer patients with negative sentinel node and no axillary dissection confirms low rate of axillary disease.
Galimberti V; Manika A; Maisonneuve P; Corso G; Salazar Moltrasio L; Intra M; Gentilini O; Veronesi P; Pagani G; Rossi E; Bottiglieri L; Viale G; Rotmensz N; De Cicco C; Grana CM; Sangalli C; Luini A
Eur J Surg Oncol; 2014 Oct; 40(10):1203-8. PubMed ID: 25186914
[TBL] [Abstract][Full Text] [Related]
27. Second axillary sentinel node biopsy for ipsilateral breast tumour recurrence.
Intra M; Trifirò G; Galimberti V; Gentilini O; Rotmensz N; Veronesi P
Br J Surg; 2007 Oct; 94(10):1216-9. PubMed ID: 17583891
[TBL] [Abstract][Full Text] [Related]
28. A prospective validation study of sentinel lymph node biopsy in multicentric breast cancer: SMMaC trial.
van la Parra RF; de Roos WK; Contant CM; Bavelaar-Croon CD; Barneveld PC; Bosscha K
Eur J Surg Oncol; 2014 Oct; 40(10):1250-5. PubMed ID: 24685336
[TBL] [Abstract][Full Text] [Related]
29. Role for sentinel lymph node dissection in the management of large (> or = 5 cm) invasive breast cancer.
Chung MH; Ye W; Giuliano AE
Ann Surg Oncol; 2001 Oct; 8(9):688-92. PubMed ID: 11597008
[TBL] [Abstract][Full Text] [Related]
30. Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment.
Milgrom S; Cody H; Tan L; Morrow M; Pesce C; Setton J; Rogers K; Arnold B; Eaton A; Catalano J; McCormick B; Powell S; Ho A
Ann Surg Oncol; 2012 Nov; 19(12):3762-70. PubMed ID: 22576064
[TBL] [Abstract][Full Text] [Related]
31. Sentinel lymph node biopsy in multicentric breast cancer: five-year results in a large series from a single institution.
Gentilini O; Veronesi P; Botteri E; Soggiu F; Trifirò G; Lissidini G; Galimberti V; Musmeci S; Raviele PR; Toesca A; Ratini S; Del Castillo A; Colleoni M; Talakhadze N; Rotmensz N; Viale G; Veronesi U; Luini A
Ann Surg Oncol; 2011 Oct; 18(10):2879-84. PubMed ID: 21479691
[TBL] [Abstract][Full Text] [Related]
32. [Axillary recurrences after sentinel lymph node biopsy in initial breast cancer].
Sampol C; Giménez M; Torrecabota J; Serra C; Canet R; Daumal J; Peña C; Gonzalez L; Hernandez E; Graner A; Pozo A; Vega F
Rev Esp Med Nucl; 2010; 29(5):241-5. PubMed ID: 20466461
[TBL] [Abstract][Full Text] [Related]
33. Sentinel lymph node biopsy in patients with multifocal breast cancer.
Goyal A; Newcombe RG; Mansel RE; Chetty U; Ell P; Fallowfield L; Kissin M; Sibbering M;
Eur J Surg Oncol; 2004 Jun; 30(5):475-9. PubMed ID: 15135472
[TBL] [Abstract][Full Text] [Related]
34. The role of sentinel node biopsy in male breast cancer.
Maráz R; Boross G; Pap-Szekeres J; Markó L; Rajtár M; Ambrózay É; Bori R; Cserni G
Breast Cancer; 2016 Jan; 23(1):85-91. PubMed ID: 24794951
[TBL] [Abstract][Full Text] [Related]
35. [Incidence of axillary recurrence after a negative sentinel lymph node result in early stages of breast cancer: a 5-year follow-up].
Ruano Pérez R; Ramos Boyero M; García-Talavera Fernández JR; Ramos Grande T; González-Orús JM; Gómez-Caminero López F; García Macias MC; Martín de Arriba A
Rev Esp Med Nucl Imagen Mol; 2012; 31(4):173-7. PubMed ID: 23067685
[TBL] [Abstract][Full Text] [Related]
36. The effect of internal mammary lymph node biopsy on the therapeutic decision and survival of patients with breast cancer.
Ozmen V; Ozcinar B; Bozdogan A; Eralp Y; Yavuz E; Dincer M
Eur J Surg Oncol; 2015 Oct; 41(10):1368-72. PubMed ID: 26210653
[TBL] [Abstract][Full Text] [Related]
37. Recurrence after sentinel lymph node biopsy with or without axillary lymph node dissection in patients with breast cancer.
Takei H; Suemasu K; Kurosumi M; Horii Y; Yoshida T; Ninomiya J; Yoshida M; Hagiwara Y; Kamimura M; Hayashi Y; Inoue K; Tabei T
Breast Cancer; 2007; 14(1):16-24. PubMed ID: 17244989
[TBL] [Abstract][Full Text] [Related]
38. Different biological and prognostic breast cancer populations identified by FDG-PET in sentinel node-positive patients: results and clinical implications after eight-years follow-up.
Agresti R; Crippa F; Sandri M; Martelli G; Tagliabue E; Alessi A; Pellitteri C; Maccauro M; Maugeri I; Barbara P; Rampa M; Moscaroli A; Ferraris C; Carcangiu ML; Bianchi G; Greco M; Bombardieri E
Breast; 2014 Aug; 23(4):334-40. PubMed ID: 24485802
[TBL] [Abstract][Full Text] [Related]
39. The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer.
Fan YG; Tan YY; Wu CT; Treseler P; Lu Y; Chan CW; Hwang S; Ewing C; Esserman L; Morita E; Leong SP
Ann Surg Oncol; 2005 Sep; 12(9):705-11. PubMed ID: 16079953
[TBL] [Abstract][Full Text] [Related]
40. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node.
Snoj M; Bracko M; Zagar I
Croat Med J; 2005 Jun; 46(3):377-81. PubMed ID: 15861515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
